Perspective Therapeutics (CATX) Operating Expenses (2010 - 2026)
Perspective Therapeutics (CATX) posted Operating Expenses of $28.4 million for Q1 2026, up 27.88% sequentially from $22.2 million in Q1 2025, and up 27.88% YoY from $22.2 million in Q1 2025.
Perspective Therapeutics (CATX) Operating Expenses (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported Operating Expenses for 17 years, with the latest figure at $28.4 million in Q1 2026.
- Quarterly Operating Expenses rose 27.88% year-over-year to $28.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.4 million (down 71.97% YoY) and the FY2025 annual result came in at $114.4 million, up 23.94% from the prior year.
- Operating Expenses climbed to $28.4 million in Q1 2026 per CATX's latest filing, from $22.2 million in the prior quarter.
- Over five years, Operating Expenses peaked at $45.2 million in Q4 2024 and troughed at $2.8 million in Q1 2022.
- A 5-year average of $15.0 million and a median of $11.2 million in 2022 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses declined 4.25% in 2023, then soared 276.41% in 2024.
- Over 5 years, Operating Expenses stood at $5.6 million in 2022, then jumped by 113.72% to $12.0 million in 2023, then jumped by 276.41% to $45.2 million in 2024, then tumbled by 50.96% to $22.2 million in 2025, then increased by 27.88% to $28.4 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $28.4 million, $22.2 million, and $45.2 million for Q1 2026, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Perspective Therapeutics | 386.08 Mn | 386.08 Mn | - | 29.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.34 Mn |
| Mar 31, 2026 | 28.36 Mn |
| Mar 31, 2025 | 22.17 Mn |
| Dec 31, 2024 | 45.22 Mn |
| Sep 30, 2024 | 19.00 Mn |
| Jun 30, 2024 | 14.79 Mn |
| Mar 31, 2024 | 13.33 Mn |
| Dec 31, 2023 | 12.01 Mn |
| Sep 30, 2023 | 10.03 Mn |
| Jun 30, 2023 | 10.34 Mn |
| Mar 31, 2023 | 9.99 Mn |
| Dec 31, 2022 | 5.62 Mn |
| Sep 30, 2022 | 10.47 Mn |
| Jun 30, 2022 | 5.85 Mn |
| Mar 31, 2022 | 2.82 Mn |
| Dec 31, 2021 | 2.86 Mn |
| Sep 30, 2021 | 3.30 Mn |
| Mar 31, 2021 | 2.13 Mn |
| Dec 31, 2020 | 2.04 Mn |
| Sep 30, 2020 | 1.96 Mn |